Neuro65/AOCN2024

Presentation information

Symposium

English

[S-40] Symposium 40「Nobel Prize research put into practical use one after another! The cutting edge of ATTR amyloidosis treatment」

Sat. Jun 1, 2024 9:45 AM - 11:45 AM Room7 (Hall D5, D Block, 5F, TIF)

Chair(s): Yoshiki Sekijima (Shinshu University School of Medicine, Japan), Yukio Ando (Department of Amyloidosis Research, Nagasaki International University, Japan)

[S-40-5] Therapeutic Biomarkers for Hereditary ATTR Amyloidosis

Mitsuto Sato (Department of Brain Disease Research, Shinshu University School of Medicinef, Japan)

photo
EDUCATION:
MD, Shinshu University, 1984
PhD, Shinshu University, 1992

RESEARCH AND PROFESSIONAL ACTIVITIES:
1984.6: Dept. of Neurology, Shinshu University
1993-1995: Visiting scholar, Dept. of Molecular Biology, Tokyo Institute of Psychiatry
1997-1999: Postdoctoral fellow, Dept. of Pathology (Prof. B. Frangione), NY Univ., USA.
2005-2011: Assistant professor, Dept. of Neurology, Kyoto Prefectural University of Medicine
2011-2013: Associate professor, Dept. of Molecular Pathobiology of Brain Diseases, KPUM
2014-2020.3: Professor, Dept. of Molecular Pathobiology of Brain Diseases, KPUM
2020.4-: Medical Director, Department of Functional Brain Imaging, Institute for Quantum Medical
Science, National Institutes for Quantum Science and Technology (QST)

PROFESSIONAL AND SOCIETY MEMBERSHIPS:
Board Member
2010~: Councilor, The Japan Society for Dementia Research
2012~: Director, The Japanese Society of Normal Pressure Hydrocephalus

MAJOR RESEARCH INTERESTS
1. Protein chemistry and biomarker development

Abstract password authentication.
You can find the password on page 15 of the program book.

Password